{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:55:42Z","timestamp":1771660542699,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"crossref","award":["272493"],"award-info":[{"award-number":["272493"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Valid estimates of cancer treatment costs are import for priority setting, but few studies have examined costs of multiple cancers in the same setting.<\/jats:p>\n            <jats:p>We performed a retrospective population-based registry study to evaluate phase-specific (initial, continuing, and terminal phase) direct medical costs and lifetime costs for 13 cancers and all cancers combined in Norway. Mean monthly cancer attributable costs were estimated using nationwide activity data from all Norwegian hospitals. Mean lifetime costs were estimated by combining phase-specific monthly costs and survival times from the national cancer registry. Scenarios for future costs were developed from the lifetime costs and the expected number of new cancer cases toward 2034 estimated by NORDCAN.<\/jats:p>\n            <jats:p>For all cancers combined, mean discounted per patient direct medical costs were Euros (EUR) 21,808 in the initial 12\u200amonths, EUR 4347 in the subsequent continuing phase, and EUR 12,085 in the terminal phase (last 12\u200amonths). Lifetime costs were higher for cancers with a 5-year relative survival between 50% and 70% (myeloma: EUR 89,686, mouth\/pharynx: EUR 66,619, and non-Hodgkin lymphoma: EUR 65,528). The scenario analyses indicate that future cancer costs are highly dependent on future cancer incidence, changes in death risk, and cancer-specific unit costs.<\/jats:p>\n            <jats:p>Gender- and cancer-specific estimates of treatment costs are important for assessing equity of care and to better understand resource consumption associated with different cancers.<\/jats:p>\n            <jats:p>Cancers with an intermediate prognosis (50%\u201370% 5-year relative survival) are associated with higher direct medical costs than those with relatively good or poor prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026523","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T14:56:31Z","timestamp":1625064991000},"page":"e26523","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Phase- and gender-specific, lifetime, and future costs of cancer"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-2870","authenticated-orcid":false,"given":"Christoffer","family":"Bugge","sequence":"first","affiliation":[{"name":"Department of Health Management and Health Economics, University of Oslo"},{"name":"Oslo Economics, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odd Terje","family":"Brustugun","sequence":"additional","affiliation":[{"name":"Section of Oncology, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Magnus","family":"S\u00e6ther","sequence":"additional","affiliation":[{"name":"Oslo Economics, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar S\u00f8nb\u00f8","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Department of Health Management and Health Economics, University of Oslo"},{"name":"Oslo Economics, Oslo"},{"name":"Institute of Public Health, University of Southern Denmark, Odense, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN: a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Engholm","year":"2010","journal-title":"Acta Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States","volume":"100","author":"Yabroff","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/s12885-016-2835-7","article-title":"Phase-specific and lifetime costs of cancer care in Ontario, Canada","volume":"16","author":"de Oliveira","year":"2016","journal-title":"BMC Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00005650-199508000-00007","article-title":"Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis","volume":"33","author":"Riley","year":"1995","journal-title":"Med Care"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jnci\/87.6.417","article-title":"Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care","volume":"87","author":"Taplin","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1200\/JCO.2004.10.170","article-title":"Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000","volume":"22","author":"Chang","year":"2004","journal-title":"J Clin Oncol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jnci\/93.6.447","article-title":"Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer","volume":"93","author":"Barlow","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"(7 suppl 1)","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/MLR.0b013e3181a2d847","article-title":"Overview of methods to estimate the medical costs of cancer","volume":"47","author":"Barlow","year":"2009","journal-title":"Med Care"},{"issue":"(8 suppl)","key":"R12-20250504","article-title":"Estimating health care costs related to cancer treatment from SEER-Medicare data","volume":"40","author":"Brown","year":"2002","journal-title":"Med Care"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199101000-00004","article-title":"Estimating the treatment costs of breast and lung cancer","volume":"29","author":"Baker","year":"1991","journal-title":"Med Care"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/hec.1640","article-title":"Estimating lifetime or episode-of-illness costs under censoring","volume":"19","author":"Basu","year":"2010","journal-title":"Health Econ"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.2016.77","article-title":"Cost of care for cancer patients in England: evidence from population-based patient-level data","volume":"114","author":"Laudicella","year":"2016","journal-title":"Br J Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MLR.0000000000000330","article-title":"Patterns of cancer care costs in a country with detailed individual data","volume":"53","author":"Blakely","year":"2015","journal-title":"Med Care"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2008.08.034","article-title":"Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data","volume":"7","author":"Lang","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(17_suppl)","key":"R18-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1403494817702336","article-title":"Nordic registry-based cohort studies: possibilities and pitfalls when combining Nordic registry data","volume":"45","author":"Maret-Ouda","year":"2017","journal-title":"Scand J Public Health"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","article-title":"Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness","volume":"45","author":"Larsen","year":"2009","journal-title":"Eur J Cancer"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4045\/tidsskr.13.1417","article-title":"Norsk pasientregister-en viktig kilde for forskning","volume":"134","author":"Bakken","year":"2014","journal-title":"Tidsskr Nor Legeforen"},{"issue":"(suppl_5)","key":"R22-20250504","doi-asserted-by":"crossref","first-page":"v41","DOI":"10.1093\/annonc\/mdg753","article-title":"European health systems and cancer care","volume":"14","author":"Micheli","year":"2003","journal-title":"Ann Oncol"},{"key":"R23-20250504","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2021.05.008","article-title":"Societal cost of cancer in Norway \u2013Results of taking a broader cost perspective","author":"Bugge","year":"2021","journal-title":"Health Policy"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40273-015-0325-4","article-title":"Cost-of-illness studies: an updated review of current methods","volume":"34","author":"Onukwugha","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.healthpol.2017.03.020","article-title":"Economic losses and burden of disease by medical conditions in Norway","volume":"121","author":"Kinge","year":"2017","journal-title":"Health Policy"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/00005650-199912000-00008","article-title":"Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer","volume":"37","author":"Brown","year":"1999","journal-title":"Med Care"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ejca.2008.11.008","article-title":"The advantage of women in cancer survival: an analysis of EUROCARE-4 data","volume":"45","author":"Micheli","year":"2009","journal-title":"Eur J Cancer"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00508-016-1088-4","article-title":"Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer: a population-based study","volume":"129","author":"Mohamad Al-Ali","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","article-title":"Cost-of-illness analysis. What room in health economics?","volume":"77","author":"Tarricone","year":"2006","journal-title":"Health Policy"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4045\/tidsskr.11.1099","article-title":"Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway","volume":"132","author":"Bakken","year":"2012","journal-title":"Tidsskr Nor Legeforen"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:34:53Z","timestamp":1746336893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026523"}},"subtitle":["A retrospective population-based registry study"],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":26,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026523","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"2020-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}